Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

NCT00027625 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators